MRNA is trading 4.1% down at $76.53 as the stock undergoes a technical pullback following a sharp rally over the past week.
- The move appears to be a correction from recent highs near $81.80, with no specific company news acting as a catalyst for the decline.
- With major indices also trading lower, broader risk-off sentiment is likely reinforcing profit-taking in the name after its recent period of strength.